Why the study?
Postoperative multimodal analgesia in ERAS continues to evolve as adjuncts are added or removed, warranting an examination of recent trends and current evidence.
This review summarizes current evidence on postoperative multimodal analgesia adjuncts in ERAS protocols to decrease opioid use.
Multimodal analgesia in ERAS reduces opioid use; leaves open optimal adjunct selection pending updated evidence.
Multimodal analgesia is an effective strategy to decrease opioid use after surgery and has been a mainstay of the surgical contribution to combat the opioid epidemic. Postoperative multimodal analgesia in Enhanced Recovery After Surgery (ERAS) continues to evolve as different adjuncts are added and removed based on the most up to date literature. This review examines recent trends in ERAS analgesia and what current evidence and research supports as well as those adjuncts that may not be as beneficial as once thought.
No takes yet. Share an insight, caveat, or question.
Burgess et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: